Stock News

ImmunoGen, Inc. (IMGN) Reaches $10.62 After 3.00% Up Move; Pioneer Investment Management Has Upped Its Humana (HUM) Holding

ImmunoGen, Inc. (NASDAQ:IMGN) Logo

Pioneer Investment Management Inc increased Humana Inc (HUM) stake by 10.84% reported in 2017Q4 SEC filing. Pioneer Investment Management Inc acquired 39,381 shares as Humana Inc (HUM)’s stock rose 9.24%. The Pioneer Investment Management Inc holds 402,658 shares with $99.89M value, up from 363,277 last quarter. Humana Inc now has $40.98B valuation. The stock increased 2.36% or $6.84 during the last trading session, reaching $296.79. About 336,576 shares traded. Humana Inc. (NYSE:HUM) has risen 31.54% since April 17, 2017 and is uptrending. It has outperformed by 19.99% the S&P500.

The stock of ImmunoGen, Inc. (NASDAQ:IMGN) is a huge mover today! The stock increased 2.91% or $0.3 during the last trading session, reaching $10.62. About 599,365 shares traded. ImmunoGen, Inc. (NASDAQ:IMGN) has risen 195.97% since April 17, 2017 and is uptrending. It has outperformed by 184.42% the S&P500.The move comes after 8 months positive chart setup for the $1.41B company. It was reported on Apr, 17 by We have $10.94 PT which if reached, will make NASDAQ:IMGN worth $42.33 million more.

Among 23 analysts covering Humana (NYSE:HUM), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Humana had 79 analyst reports since July 30, 2015 according to SRatingsIntel. Jefferies maintained Humana Inc. (NYSE:HUM) rating on Thursday, August 4. Jefferies has “Buy” rating and $217 target. As per Wednesday, June 7, the company rating was initiated by Morgan Stanley. The rating was reinitiated by Bank of America on Friday, January 27 with “Buy”. RBC Capital Markets maintained Humana Inc. (NYSE:HUM) rating on Monday, November 9. RBC Capital Markets has “Sector Perform” rating and $215 target. The firm earned “Hold” rating on Monday, June 5 by RBC Capital Markets. The firm earned “Neutral” rating on Friday, July 8 by JP Morgan. The stock of Humana Inc. (NYSE:HUM) earned “Hold” rating by J.P. Morgan on Monday, October 9. Argus Research upgraded the shares of HUM in report on Friday, June 9 to “Buy” rating. Leerink Swann maintained Humana Inc. (NYSE:HUM) on Thursday, February 8 with “Buy” rating. The firm has “Buy” rating by Piper Jaffray given on Tuesday, April 3.

Investors sentiment decreased to 1.05 in 2017 Q4. Its down 0.16, from 1.21 in 2017Q3. It dropped, as 40 investors sold HUM shares while 209 reduced holdings. 69 funds opened positions while 193 raised stakes. 125.53 million shares or 4.46% less from 131.39 million shares in 2017Q3 were reported. 26,523 are held by Utah Retirement. Nikko Asset Mngmt Americas owns 1,200 shares for 0.01% of their portfolio. Bartlett And Lc reported 0% stake. Kepos Cap LP invested in 15,576 shares. Glenmede Tru Company Na accumulated 197,186 shares. Principal Gp owns 251,152 shares or 0.06% of their US portfolio. Tiaa Cref Investment Ltd Liability holds 0.21% or 1.30 million shares in its portfolio. Cibc World Markets Corporation has invested 0.14% in Humana Inc. (NYSE:HUM). The New York-based Perella Weinberg Ptnrs Capital Management Limited Partnership has invested 0.26% in Humana Inc. (NYSE:HUM). Meeder Asset Mgmt invested in 0.39% or 18,338 shares. Icon Advisers Inc Co holds 0.12% of its portfolio in Humana Inc. (NYSE:HUM) for 7,100 shares. Central Fincl Bank holds 0.93% of its portfolio in Humana Inc. (NYSE:HUM) for 15,548 shares. State Of Tennessee Treasury Department holds 58,300 shares or 0.06% of its portfolio. Cullen Frost Bankers Inc owns 1,074 shares for 0.01% of their portfolio. Whittier Tru Co Of Nevada has invested 0% in Humana Inc. (NYSE:HUM).

Since December 15, 2017, it had 0 insider buys, and 10 selling transactions for $20.82 million activity. Fleming William Kevin had sold 1,073 shares worth $295,450. Shares for $326,899 were sold by Zipperle Cynthia H on Friday, March 9. 2,931 shares were sold by BILNEY JODY L, worth $801,477. LeClaire Brian P. sold 12,719 shares worth $3.49 million. On Wednesday, February 28 MARGULIS HEIDI S sold $1.03M worth of Humana Inc. (NYSE:HUM) or 3,727 shares. Another trade for 16,270 shares valued at $4.45 million was sold by Huval Timothy S.. $3.86 million worth of stock was sold by BROUSSARD BRUCE D on Saturday, February 24.

Pioneer Investment Management Inc decreased Timkensteel Corp (NYSE:TMST) stake by 81,965 shares to 205,896 valued at $3.13 million in 2017Q4. It also reduced General Cable Corporation (Prn) stake by 4.25M shares and now owns 23.81 million shares. Anadarko Pete Corp (Call) (NYSE:APC) was reduced too.

Investors sentiment increased to 1.38 in 2017 Q4. Its up 0.22, from 1.16 in 2017Q3. It increased, as 26 investors sold ImmunoGen, Inc. shares while 39 reduced holdings. 37 funds opened positions while 53 raised stakes. 101.53 million shares or 15.77% more from 87.70 million shares in 2017Q3 were reported. Moreover, Raymond James Fincl has 0% invested in ImmunoGen, Inc. (NASDAQ:IMGN) for 12,084 shares. Federated Invsts Pa invested in 17,213 shares. Pinnacle Assocs Ltd holds 0.16% or 1.32 million shares. Fisher Asset Mngmt Ltd Com owns 158,476 shares. Panagora Asset Management has invested 0.02% in ImmunoGen, Inc. (NASDAQ:IMGN). State Of Wisconsin Investment Board owns 0% invested in ImmunoGen, Inc. (NASDAQ:IMGN) for 58,000 shares. Geode Mgmt Lc has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Primecap Mgmt Ca accumulated 3.82M shares. Lpl Financial Ltd Limited Liability Company holds 0% or 45,994 shares in its portfolio. Ameritas Investment Ptnrs owns 7,913 shares. Hall Laurie J Trustee reported 0% stake. Alps Advsrs reported 146,549 shares. The New York-based Alliancebernstein L P has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Virginia Retirement System Et Al stated it has 48,000 shares or 0% of all its holdings. Raymond James holds 619,357 shares or 0.01% of its portfolio.

Among 9 analysts covering Immunogen (NASDAQ:IMGN), 6 have Buy rating, 1 Sell and 2 Hold. Therefore 67% are positive. Immunogen has $24 highest and $500 lowest target. $14.75’s average target is 38.89% above currents $10.62 stock price. Immunogen had 31 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of ImmunoGen, Inc. (NASDAQ:IMGN) earned “Underweight” rating by Morgan Stanley on Monday, September 21. Jefferies maintained the stock with “Buy” rating in Sunday, August 6 report. The firm has “Buy” rating given on Wednesday, August 30 by Canaccord Genuity. The rating was maintained by Canaccord Genuity with “Buy” on Monday, March 26. The firm earned “Hold” rating on Friday, July 28 by Cowen & Co. Cowen & Co maintained the shares of IMGN in report on Tuesday, August 29 with “Hold” rating. Jefferies maintained it with “Buy” rating and $600 target in Monday, June 26 report. The rating was upgraded by Jefferies on Wednesday, November 25 to “Buy”. The firm earned “Buy” rating on Thursday, February 1 by Canaccord Genuity. The firm has “Hold” rating given on Sunday, June 4 by Cowen & Co.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *